Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Silencing of LncRNA-ANCR Promotes the Osteogenesis of Osteoblast Cells in Postmenopausal Osteoporosis via Targeting EZH2 and RUNX2

1 Jan 2019

Abstract excerpt

PURPOSE: This study aimed to explore the effects and mechanisms of long non-coding RNA (lncRNA) anti-differentiation non-coding RNA (ANCR) on the osteogenesis of osteoblast cells in postmenopausal osteoporosis (PMOP). MATERIALS AND METHODS: Mice models of PMOP were established. ANCR expression and intracellular calcium ions were detected by quantitative real-time polymerase chain reaction (qRT-PCR) and laser...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Metabolism and Diseases
Share to Cancer-related molecular mechanisms research
Share to Heterotopic Ossification and Related Conditions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31347330
DOI: 10.3349/ymj.2019.60.8.751

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Silencing of LncRNA-ANCR Promotes the Osteogenesis of Osteoblast Cells in Postmenopausal Osteoporosis via Targeting EZH2 and RUNX2PMID 31347330Read ↗

LINC00899 promotes osteogenic differentiation and alleviates osteoporosis via targeting miR-374a to regulate RUNX2Semantic proximity Read ↗

The Roles of LncRNAs in Osteogenesis, Adipogenesis and OsteoporosisSemantic proximity Read ↗

Long non‑coding RNA RP11‑84C13.1 promotes osteogenic differentiation of bone mesenchymal stem cells and alleviates osteoporosis progression via the miR‑23b‑3p/RUNX2 axisSemantic proximity Read ↗

The Involvement of microRNAs in Bone Remodeling Signaling Pathways and Their Role in the Development of OsteoporosisSemantic proximity Read ↗

RUNX2 co‐operates with EGR1 to regulate osteogenic differentiation through Htra1 enhancersSemantic proximity Read ↗

An Overview of Long Noncoding RNAs Involved in Bone Regeneration from Mesenchymal Stem CellsSemantic proximity Read ↗

Long non-coding RNAs in bone formation: Key regulators and therapeutic prospectsSemantic proximity Read ↗

Emerging Roles of Natural Compounds in Osteoporosis: Regulation, Molecular Mechanisms and Bone RegenerationSemantic proximity Read ↗

Transient downregulation of NR4A1 leads to impaired osteoblast differentiation through the TGF-ß pathway, and Elesclomol (STA-4783) rescues this phenotype.Semantic proximity Read ↗

MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for OsteoporosisSemantic proximity Read ↗

m6A Methylation Regulates Osteoblastic Differentiation and Bone RemodelingSemantic proximity Read ↗

LncRNA DANCR and miR-320a suppressed osteogenic differentiation in osteoporosis by directly inhibiting the Wnt/β-catenin signaling pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.